Clinical trial
Chloroquine for Treatment of Glioblastoma Multiforme
NCT00224978 · National Institute of Neurology and Neurosurgery, Mexico, Other · Completed
Key facts
| NCT number | NCT00224978 |
|---|---|
| Title | Chloroquine for Treatment of Glioblastoma Multiforme |
| Official title | Chloroquine as Adjuvant to the Treatment of Glioblastoma Multiforme, A Randomized Trial |
| Lead sponsor | National Institute of Neurology and Neurosurgery, Mexico, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Glioblastoma Multiforme |
| Intervention type | Drug |
| Interventions | Chloroquine |
| Start date | Jan 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Sep 23, 2005 |
| Last update posted | Nov 18, 2009 |
| Countries | Mexico |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: